CONCORDBIO.BOCONCORDBIO.BOBSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+22.7%
5Y CAGR+19.1%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+22.7%/yr
Annual compound
5Y CAGR
+19.1%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$5.13B+16.9%
2024$4.39B+24.4%
2023$3.53B+26.9%
2022$2.78B-15.5%
2021$3.29B+53.6%
2020$2.14B-